If you are using or recommending this test, this might be of interest with the latest FDA action until it is determined if the the specifications meet the specifications as developed at Yale. BD The FDA has warned clinical-test giant LabCorp that it has been marketing an ovarian cancer test...
If you want to do some reading up on the topic, this site may offer some help, along with the upcoming conference to be held here in the Los Angeles area in October. As posted recently there are plans for many of the service companies, such as 23andMe , Navigenics , DeCode, LabCorp , and perhaps...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-11-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Physician, personalized medicine, Genomics, Cancer, Pharmacogenomics, Patients, Genonimic Testing, Human Genome Project, Genomic Counseling, Lab Tests